Reply to Z. Blumenfeld et al

J Clin Oncol. 2013 Oct 10;31(29):3722-3. doi: 10.1200/JCO.2013.50.7129. Epub 2013 Sep 3.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Estradiol / blood*
  • Female
  • Follicle Stimulating Hormone / blood*
  • Gonadotropin-Releasing Hormone / agonists*
  • Humans
  • Lymphoma / drug therapy*
  • Premenopause*
  • Primary Ovarian Insufficiency / chemically induced*
  • Primary Ovarian Insufficiency / prevention & control*
  • Triptorelin Pamoate / therapeutic use*

Substances

  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Estradiol
  • Follicle Stimulating Hormone